|
FY2025
8 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net income | |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Change in fair value of warrant liability | |
| Dividends earned on marketable securities held in Trust Account | |
| Changes in operating assets and liabilities: | |
| Accounts payable and accrued expenses | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Cash deposited into Trust Account | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Proceeds from Initial Public Offering | |
| Proceeds from issuance of ordinary shares to Sponsor | |
| Proceeds from private placement | |
| Payment of offering costs | |
| Advances to related party, net | |
| Net cash provided by financing activities | |
| Supplemental disclosure of non-cash financing and investing activities: | |
| Initial value of Class A ordinary shares subject to possible redemption | |
| Change In Value Of Common Stock Subject To Redemption | |
| Accretion of Class A ordinary shares to redemption value | |
| Deferred underwriting fee payable upon Business Combination | |
| Initial fair value of warrant liability recognized |
Loading...
